Stochter
Profile Picture
The Investor 19 Nov 2026, 18:44
Post Image
Zoetis Wins USDA License for 3-in-1 Poultry Vaccine

Zoetis (NYSE: ZTS) received a U.S. Department of Agriculture license for Poulvac Procerta HVT-ND-ILT, a new vector vaccine designed to protect chickens against Marek’s disease, Newcastle disease and infectious laryngotracheitis.

The 3-in-1 vaccine is labeled for use in healthy one-day-old chickens or 18- to 19-day-old embryonated eggs and is intended to give veterinarians and poultry producers greater flexibility when designing flock-health programs.

The product expands Zoetis’ existing poultry vaccine portfolio, which also includes solutions targeting infectious bursal disease, infectious bronchitis, Salmonella and E. coli. The company said Poulvac Procerta HVT-ND-ILT can also be incorporated into seasonal or rotational infectious laryngotracheitis vaccination strategies.

The USDA license strengthens Zoetis’ poultry-health offering by adding a broader combination vaccine to its U.S. portfolio. While the announcement does not include financial guidance, the approval expands the company’s addressable opportunity in commercial poultry disease prevention.

Comments

No comments yet.

Ana sayfa